Jen Hsun Huang Files Form 144 for 75,000 NVIDIA Shares with Charles Schwab
Rhea-AI Filing Summary
Form 144 filed for NVIDIA Corporation (NVDA). The notice shows proposed sale of 75,000 common shares through Charles Schwab & Co., Inc. with an aggregate market value of $13,286,198 and the approximate sale date listed as 09/25/2025. The shares were acquired on 12/08/2022 by option exercise and payment was in cash. The filing also lists many prior sales by Jen Hsun Huang of 75,000 shares on multiple dates from 06/25/2025 through 09/24/2025, each showing gross proceeds per sale. The filing reports 24,300,000,000 shares outstanding for the issuer as stated in the form.
Positive
- Clear compliance with Rule 144 through formal notice and signature representation
- Detailed transaction disclosure including acquisition date, nature (option exercise), broker, and gross proceeds for prior sales
Negative
- Insider selling activity is extensive: many 75,000-share sales by the insider are listed between 06/25/2025 and 09/24/2025
- No 10b5-1 plan date provided on the form, so the filing does not indicate whether sales were pursuant to a pre-established trading plan
Insights
TL;DR: Insider disclosed routine sales of equal-sized blocks; transaction details are clearly reported under Rule 144.
The filing documents a proposed sale of 75,000 common shares acquired by option exercise on 12/08/2022 and lists numerous completed 75,000-share sales by the same insider from 06/25/2025 through 09/24/2025. The use of a registered broker and explicit gross proceeds per sale improves transparency for market participants. This disclosure allows investors to track insider liquidity activity but does not, by itself, provide company operating or financial performance information.
TL;DR: The filing reflects compliant insider selling with required representations; it raises governance questions only if pattern signals ongoing disposition.
The notice includes the seller's representation regarding material nonpublic information and indicates the shares were acquired via option exercise. Repeated periodic sales are documented, which is appropriate for compliance with trading rules. From a governance perspective, disclosure is complete on the mechanics of the trades; the filing does not include any statements about trading plans or 10b5-1 adoption dates, so no inference on preplanned trading can be drawn from this document alone.